0001209191-14-067326.txt : 20141107
0001209191-14-067326.hdr.sgml : 20141107
20141107162652
ACCESSION NUMBER: 0001209191-14-067326
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20141105
FILED AS OF DATE: 20141107
DATE AS OF CHANGE: 20141107
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Silva Paul M
CENTRAL INDEX KEY: 0001446372
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 141205248
MAIL ADDRESS:
STREET 1: C/O VERTEX PHARMACEUTICALS INCORPORATED
STREET 2: 130 WAVERLY ST
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2014-11-05
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001446372
Silva Paul M
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON
MA
02210
0
1
0
0
SVP & Corp Controller
Common Stock
2014-11-05
4
M
0
1687
45.11
A
18687
D
Common Stock
2014-11-05
4
S
0
887
112.07
D
17800
D
Common Stock
2014-11-05
4
S
0
700
112.93
D
17100
D
Common Stock
2014-11-05
4
S
0
100
114.29
D
17000
D
Common Stock
169
I
401(k)
Stock Option (right to buy)
45.11
2014-11-05
4
M
0
1687
0.00
D
2023-02-04
Common Stock
1687
15188
D
Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1.
Mr. Silva undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $112.07 (range $111.54 to $112.32).
Open market sales reported on this line occurred at a weighted average price of $112.93 (range $112.60 to $113.49).
The option vests in 16 quarterly installments from 02/05/2013.
Omar White, Attorney-In-Fact
2014-11-07